Elizabeth HernbergStahl Email & Phone Number | Elizabeth has more than thirty years experience from International Biotech and Pharmaceutical Industry; whereof near twenty in the orphan drug sector and late phase drug development. Elizabeth has an in-depth expertise on orphan diseases and drugs as well as the designing and management of patient registries within this area. Elizabeth has a proven track record of successful collaboration with patient registry stakeholders (patient organizations, treating physicians, authorities, payers) by assuring registry output fulfills their different needs as well as the ability to connect pharma business opportunities with patient registry design, management and outcome. Elizabeth has published numerous scientific papers, contributed to books related to Orphan Drugs and diseases. She is a frequent speaker and trainer at many international venues organized by industry, patient organizations or other stakeholders within the field of rare diseases and orphan drugs; • World Orphan Drug Congress Geneva 29-30 November 2012; Natural history studies: setting the stage for successful orphan drug development •Orphan Drugs & Rare Diseases; Innovative strategies for getting orphan drugs to where they are needed.London 8-10 October 2012 •17th ISPOR Annual International Congress; Short Course; Patient Registries,Washington, DC, USA 2-6 June 2012 •2nd Annual Optimizing Orphan Drug Development, Lyon 19-20 January 2012 •Innovative Solutions to Data Capture, Late Phase Drug development World London 6 December 2011 •14th ISPOR Annual European Congress; Short Course ; Patient Registries,Madrid 5 November 2011 •Rare Disease Research Forum, Karolinska Institute, Stockholm, 21 February 2011 •1st World Orphan Drug Congress, Geneva November 29-December 1, 2010 •13th ISPOR Annual European Congress; Short Course Real World Data; Patient Registries,Prague 6 November 2010 •5th European Conference on Rare Diseases ECRD Krakow 13-15 May 2010 Specialties: Provide strategic and operational guidance on Late Phase Drug Development as well as guidance on processes and activities related to Orphan Drug Development and Market Access; e.g. observational studies/patient registries for e.g. conditional approvals/market access/ pricing and reimbursement. Leading/managing Expert and Scientific Advisory Groups as well as coaching and developing teams.

Elizabeth HernbergStahl

Elizabeth has more than thirty years experience from International Biotech and Pharmaceutical Indust...
Täby, Stockholm County, Sweden

*50 free lookup(s) per month.

No credit card required.

Elizabeth HernbergStahl’s Email e.hernbergstahl@latephasesolutions.com

Elizabeth HernbergStahl’s Phone Numbers

Get ELIZABETH’s Phone Number (For Free)

Social Media

Elizabeth HernbergStahl’s Location Täby, Stockholm County, Sweden

Elizabeth HernbergStahl’s Current Industry Late Phase Solutions Europe

Elizabeth HernbergStahl’s Prior Industry Shire Hgt | Pharmacia | Kabi Pharmacia | Pharmacia Diagnostics

Not the Elizabeth HernbergStahl you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Late Phase Solutions Europe

Senior Consultant and Founder

2010-02-01 00:00:00 - Present

Shire Hgt

Director, Global Outcome Surveys

2000-10-01 00:00:00 - 2010-02-01 00:00:00

Pharmacia

Project Manager, KIGS/KIMS Outcomes Research

1993-01-01 00:00:00 - 2000-09-01 00:00:00

Kabi Pharmacia

CRA Medical Department

1992-01-01 00:00:00 - 1992-12-01 00:00:00

Pharmacia Diagnostics

Quality Assurance Manager

1991-01-01 00:00:00 - 1991-12-01 00:00:00

Skills

No Skills Available

Languages

No Languages Available

FAQ About Elizabeth HernbergStahl

Elizabeth HernbergStahl is located at
Täby, Stockholm County, Sweden

Elizabeth HernbergStahl is a Elizabeth has more than thirty years experience from International Biotech and Pharmaceutical Industry; whereof near twenty in the orphan drug sector and late phase drug development. Elizabeth has an in-depth expertise on orphan diseases and drugs as well as the designing and management of patient registries within this area. Elizabeth has a proven track record of successful collaboration with patient registry stakeholders (patient organizations, treating physicians, authorities, payers) by assuring registry output fulfills their different needs as well as the ability to connect pharma business opportunities with patient registry design, management and outcome. Elizabeth has published numerous scientific papers, contributed to books related to Orphan Drugs and diseases. She is a frequent speaker and trainer at many international venues organized by industry, patient organizations or other stakeholders within the field of rare diseases and orphan drugs; • World Orphan Drug Congress Geneva 29-30 November 2012; Natural history studies: setting the stage for successful orphan drug development •Orphan Drugs & Rare Diseases; Innovative strategies for getting orphan drugs to where they are needed.London 8-10 October 2012 •17th ISPOR Annual International Congress; Short Course; Patient Registries,Washington, DC, USA 2-6 June 2012 •2nd Annual Optimizing Orphan Drug Development, Lyon 19-20 January 2012 •Innovative Solutions to Data Capture, Late Phase Drug development World London 6 December 2011 •14th ISPOR Annual European Congress; Short Course ; Patient Registries,Madrid 5 November 2011 •Rare Disease Research Forum, Karolinska Institute, Stockholm, 21 February 2011 •1st World Orphan Drug Congress, Geneva November 29-December 1, 2010 •13th ISPOR Annual European Congress; Short Course Real World Data; Patient Registries,Prague 6 November 2010 •5th European Conference on Rare Diseases ECRD Krakow 13-15 May 2010 Specialties: Provide strategic and operational guidance on Late Phase Drug Development as well as guidance on processes and activities related to Orphan Drug Development and Market Access; e.g. observational studies/patient registries for e.g. conditional approvals/market access/ pricing and reimbursement. Leading/managing Expert and Scientific Advisory Groups as well as coaching and developing teams.

Elizabeth HernbergStahl currently works in the Late Phase Solutions Europe |

No Languages Available

Elizabeth HernbergStahl has prior
experience in the following industries:
Shire Hgt | Pharmacia | Kabi Pharmacia | Pharmacia Diagnostics

Elizabeth HernbergStahl has the following professional experience:
Late Phase Solutions Europe | Shire Hgt | Pharmacia | Kabi Pharmacia | Pharmacia Diagnostics